Literature DB >> 11953286

A sebaceous tumor in a patient with acquired immunodeficiency syndrome.

Stefan Frantz1, A Greiner, C Schoen, P Langmann, H Klinker.   

Abstract

The prevalence of cutaneous malignancies is higher in immunosuppressed patients. Here, we describe a case with a rapid growing and unusually large sebaceous tumor in a patient with acquired immunodeficiency syndrome. Sebaceous adenomas are commonly rare, benign tumors of sebaceous glands. An association of AIDS and a solitary, large sebaceous adenoma has not been described yet. This emphasizes the role of an intact immune system in the suppression of benign and malignant tumors. tubular adenoma; tumor; AIDS

Entities:  

Mesh:

Year:  2002        PMID: 11953286

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  5 in total

1.  Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults.

Authors:  Emilie Lanoy; Dominique Costagliola; Eric A Engels
Journal:  Int J Cancer       Date:  2010-04-01       Impact factor: 7.396

2.  Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.

Authors:  Graça M Dores; Rochelle E Curtis; Jorge R Toro; Susan S Devesa; Joseph F Fraumeni
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

3.  Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Authors:  Emilie Lanoy; Graça M Dores; Margaret M Madeleine; Jorge R Toro; Joseph F Fraumeni; Eric A Engels
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

4.  Sebaceous adenoma in the setting of immunosuppression for kidney transplantation.

Authors:  Jacob Reinhart; William D James
Journal:  JAAD Case Rep       Date:  2019-08-30

5.  Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study.

Authors:  Srishti Gupta; Mohnish Suri; Cris S Constantinescu
Journal:  Neurol Ther       Date:  2020-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.